重组蛋白A
91932-65-9
|
重组蛋白酶K
39450-01-6
|
组蛋白
9064-47-5
|
组蛋白脱乙酰酶抑制剂
183506-66-3
|
组蛋白乙酰转移酶抑制剂II
932749-62-7
|
H1-7(组蛋白H1磷酸化位点),PKA底物
65189-70-0
|
组织蛋白酶抑制剂1
225120-65-0
|
组织蛋白酶H
60748-73-4
|
组织蛋白酶抑制剂2
1017931-53-1
|
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
|
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
|
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
|
3-[(2,2-difluoroethoxy)methyl]-4-iodo-1-isobutyl-1H-pyrazole
1856031-67-8
|
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
|
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
|
tert-butyl N-[1-(6-ethylpyrimidin-4-yl)pyrrolidin-3-yl]carbamate
2098009-46-0
|
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
930439-75-1
|
4-Thiazolecarboxamide, 2-(2-aminoethyl)-N-[2-[methyl(phenylmethyl)amino]propyl]-
1833400-04-6
|
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
1018584-77-4
|